NLM Logo

ixekizumab MeSH Supplementary Concept Data 2025


MeSH Supplementary
ixekizumab
Unique ID
C549079
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C549079
Entry Term(s)
LY-2439821
LY2439821
Taltz
Pharm Action
Dermatologic Agents
Registry Numbers
BTY153760O
Previous Indexing
*ANTIBODIES, MONOCLONAL (2010-2011)
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
451
Note
A humanized anti-interleukin 17 monoclonal antibody used for the treatment of PSORIASIS.
Source
Arthritis Rheum. 2010 Apr;62(4):929-39
Indexing Information
Interleukin-17
Date of Entry
2010/05/03
Revision Date
2021/02/12
ixekizumab Preferred
LY2439821 Narrower
Taltz Narrower
page delivered in 0.005s